BB&T Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

BB&T Securities’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.81M	Sell	14,055 -242	-2%	-$71.6K	0.03%	434
2019 Q2	$4.47M	Buy	14,297 +1,914	+15%	+$637K	0.04%	410
2019 Q1	$5.08M	Sell	12,383 -377	-3%	-$155K	0.05%	378
2018 Q4	$4.76M	Buy	12,760 +227	+2%	+$83.1K	0.05%	369
2018 Q3	$5.06M	Buy	12,533 +1,093	+10%	+$416K	0.05%	390
2018 Q2	$3.95M	Buy	11,440 +4,038	+55%	+$1.26M	0.04%	430
2018 Q1	$2.55M	Buy	7,402 +4,226	+133%	+$1.47M	0.03%	522
2017 Q4	$1.19M	Buy	3,176 +145	+5%	+$58.7K	0.02%	684
2017 Q3	$1.35M	Buy	3,031 +535	+21%	+$255K	0.02%	647
2017 Q2	$1.23M	Buy	2,496 +864	+53%	+$378K	0.02%	658
2017 Q1	$632K	Buy	+1,632	New	+$605K	0.01%	808

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

BB&T Securities's REGN Position: Q3 2019 in Review

BB&T Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q3 2019, selling an estimated $71.6K and leaving 14,055 shares worth $3.81M. The position accounts for 0.03% of the portfolio, ranked #434.

BB&T Securities first reported a position in REGN in Q1 2017 and has held it in 11 quarters since. The position peaked at $5.08M in Q1 2019. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

BB&T Securities held 14,055 shares of Regeneron Pharmaceuticals worth $3.81M as of Q3 2019.
BB&T Securities sold 242 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $71.6K.
Regeneron Pharmaceuticals made up 0.03% of BB&T Securities's portfolio in Q3 2019, its #434 holding.
BB&T Securities first reported a position in Regeneron Pharmaceuticals in Q1 2017 and has held it in 11 quarters since.
BB&T Securities's Regeneron Pharmaceuticals position peaked at $5.08M in Q1 2019.
633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.